Roots Analysis

MARCH 9, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies), by the US FDA, have steadily risen. Biopharmaceutical Excipient Manufacturing Market. Biopharmaceutical Excipient Manufacturing Market. Capacity Analysis.

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

Roots Analysis

MARCH 16, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. Furthermore, these drug candidates can be used to develop precise and individualized therapies that allow patients to produce therapeutic proteins in their own bodies.

Vaccination 52

Vaccination Vaccine DNA Protein 52

Drug Discovery World

APRIL 3, 2023

I quickly recognised the commercial value of aptamers as being able to address the gap in the market where antibodies fail to perform, and together we established the business to begin aptamer development. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

pharmaphorum

NOVEMBER 7, 2022

The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. Engage in the regulatory landscape of ophthalmic drugs and key considerations for R&D.

Drugs 52

Drugs Clinical Trials Clinical Trials Gene Therapy 52

Drug Discovery World

APRIL 29, 2024

He holds a PhD in Chemistry for early work on antibody drug conjugates in 1987 and was awarded the Bioprocessing Lifetime Achievement Award in 2021. Carbone brings over 35 years of experience in operations, quality, and technology leadership in biotechnology, pharmaceuticals, and advanced therapies.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

Drug Discovery World

FEBRUARY 5, 2024

This is EXO Biologics’ lead MSC-based exosome candidate for prevention of Bronchopulmonary Dysplasia (BPD) in preterm newborns. “The potential of exosomes continues to be demonstrated across the cell and gene therapy sector.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Gene Therapy 52

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years.

Drug Delivery 40

Drug Delivery Marketing Insulin Manufacturing 40

Delveinsight

FEBRUARY 14, 2021

Pharmaceutical companies sell their orphan drugs at astronomical prices such that many patients are not able to afford them. Past years saw an increase in the entry of Orphan drugs in the market – at higher rates than ever before, and it is hurting the families and patients. Funding is an issue!

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Future Evolution of Biopharmaceutical Excipient Manufacturing Market. Our Social Media Platform. Web: [link]. LinkedIn: [link].

Manufacturing 52

Manufacturing Drug Delivery Marketing Drug Delivery Systems 52

XTalks

AUGUST 30, 2022

One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.

Trials 83

Trials Drug Delivery Drugs Gene 83

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026.

Doctors 57

Doctors Doctor Sales Medicine 57

The Pharma Data

JUNE 26, 2021

The PDS Marketing Authorisation Application has also been validated by the European Medicines Agency and is currently under review. About Roche in Ophthalmology Roche is focused on saving people’s eyesight from the leading causes of vision loss through pioneering therapies.

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

NOVEMBER 9, 2023

Nick Pittman, Marketing Manager, Global Biopharmaceutical Business, Waters Corporation, on: ‘Robust multi-level LC-MS workflows for biosimilar comparability assessment’. Kris Ver Donck, Vice President, Marketing & Applications, FOx BIOSYSTEMS, on: ‘Using FO-SPR to select for efficient antigen binders in phage display’.

Engineer 52

Engineer Antibody Protein In-Vivo 52